Skip to main content
EOFlow Co., Ltd. logo

EOFlow Co., Ltd. — Investor Relations & Filings

Ticker · 294090 ISIN · KR7294090006 KO Manufacturing
Open in API
Filings indexed 458 across all filing types
Latest filing 2026-05-18 Director's Dealing
Country KR South Korea
Listing KO 294090

About EOFlow Co., Ltd.

https://www.eoflow.com

EOFlow Co., Ltd. is a medical device company that develops and provides wearable drug delivery solutions. Its flagship product is the EOPatch, a disposable, wearable insulin pump system designed for the continuous delivery of insulin to manage blood glucose levels in individuals with diabetes. The company leverages its proprietary technology and manufacturing expertise to create reliable and accessible drug delivery platforms. EOFlow also collaborates with partners to integrate its pump technology into automated insulin delivery (AID) systems, advancing diabetes care management.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 91% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” filed to the Financial Services Commission and Korea Exchange. It details an officer’s (CFO 권대우) personal shareholding and changes (acquisitions via purchase and stock options). This is clearly a director’s insider transaction report rather than a general voting result or dividend notice.
2026-05-18 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 98% confidence The document is titled “분기보고서” (Quarterly Report) for the period January 1, 2026 to March 31, 2026, includes detailed company overview, product descriptions, financial tables, production data, R&D activities, etc. It is the full interim/quarterly financial report itself, not merely an announcement or summary. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
반기또는분기매출액미달사실발생
Regulatory Filings Classification · 90% confidence The document is a short regulatory disclosure notifying that quarterly (or half-year) revenues fell below a specified threshold (3억원). It does not contain a full interim report or earnings release, nor strategic discussion, but rather a compliance notice under listing rules. This fits the fallback category for general regulatory announcements (RNS).
2026-05-15 Korean
주권매매거래정지기간변경 (상장적격성 실질심사 대상(사유발생))
Regulatory Filings Classification · 82% confidence The document is a regulatory exchange announcement about changing the trading suspension period for a listed security due to listing qualification review. It is not a financial report, earnings release, dividend notice, or delisting notice but a general regulatory filing. Therefore it falls under the fallback category ‘Regulatory Filings (RNS)’.
2026-05-15 Korean
기타시장안내 (상장적격성 실질심사 관련)
Regulatory Filings Classification · 78% confidence The document is a market notice from the exchange informing that the company has triggered a listing eligibility review due to quarterly sales below thresholds under KOSDAQ rules. It is not a financial report (e.g., 10-K or IR), not a management change, nor an earnings release. It does not present actual financial statements but is a regulatory announcement. Therefore, it falls under Regulatory Filings (RNS).
2026-05-15 Korean
기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)
Regulatory Filings Classification · 98% confidence Document is a Korean stock exchange announcement (“기타시장안내”) informing the company about timing for the listing eligibility substantive review decision. It is an exchange regulatory notice, not an earnings/financial report or management presentation. Falls under general regulatory filings (RNS).
2026-05-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.